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ABSTRACT 
Virtual Reality (VR) sickness seems one of the main limitations to the 
large-scale adoption of VR technologies. This disturbance seems to 
induce physiological changes that affect the sympathetic and 
parasympathetic activities of the users. Thereby, it seems relevant to 
measure users’ physiological data in order to prevent and reduce VR 
sickness. This paper presents the results of an initial real-life experiment of 
VR sickness detection based on physiological data. The electrodermal, 
cardiac and subjective data of 27 participants was recorded during VR 
sessions. Machine Learning algorithms were trained and the best model 
(Gradient Boosting) explained 48% of the VR sickness variance. These 
results demonstrate the opportunity to develop an automatic and 
continuous tool to detect the appearance of VR sickness based on 
physiological signals. This tool will prove very valuable to the VR industry. 
 
INTRODUCTION 
Virtual Reality (VR) appears as a major technological breakthrough and a main business 
opportunity for the entertainment industry. The VR market is expected to expand 
exponentially with worldwide revenues for the AR/VR growing to more than $162 billion in 
2020 [1]. However, one main limitation to its large-scale adoption is VR sickness especially 
because of health, ethical, legal and acceptability aspects. VR sickness is a common 
problem that could affect up to 60% of adult users [2].   
The necessity to better detect and prevent the appearance of VR sickness is at the origin 
of this research cooperation between b<>com and Editorial user research lab, Ubisoft 
Paris aiming at the development of an automatic VR sickness detection tool. 
VIRTUAL REALITY SICKNESS: CAUSES AND SYMPTOMS 
Previous research proposed several hypotheses to explain VR Sickness. The most 
common theory is the sensory conflict theory [3]. According to this theory, VR sickness is 
the result of conflicts and inconsistency between the different sensorial information sent to 
the brain when the user evolves in the virtual world. In VR, the most common conflict is a 
discrepancy between the motion information coming from the vestibular system and the 
motion information coming from the visual system. Indeed, this information comes from 
two separate systems: the vestibular system located in the inner ear and the visual system 
        
[4]. This discrepancy will be detected by the brain and will induce, in sensitive participants, 
the symptoms of VR sickness.  
VR sickness is a complex phenomenon and while motion cues play a primary role, multiple 
factors are known to contribute to the appearance of the sickness. Three main categories 
of factors can be identified:  
1) The factors related to the characteristics of the stimuli: the spatial frequency [5], the 
reactivity of the system [6], the wideness of the Field Of View (FOV) [7], etc. 
2) The factors related to the predispositions of the users: gender [8], age [9], the 
predisposition to suffer from migraine attack [10], etc. 
3) The users’ past experiences [11], according to the sensory conflict theory. In fact 
VR sickness appears only when a present set of vestibular and visual information is 
not congruent with what is expected from previous experiences [12].  
The complex nature of VR sickness is not limited to its different causes, but it is reflected 
in its symptomatology as well. While the most evident and detrimental symptom of VR 
sickness is the nausea, the complete symptomatology of VR sickness includes other 
elements like general discomfort, headache, disorientation and eye strain. The intensity as 
well as the duration of the symptoms are quite variable. They depend on the characteristic 
of the stimulus and the user predisposition to VR sickness. In the majority of cases, the 
symptoms disappear some minutes after the end of the stimulation. Nevertheless, there 
are documented cases when the symptoms were still present 6 hours after the VR 
experience [13].  
THE ASSESSMENT OF VIRTUAL REALITY SICKNESS 
The traditional way to evaluate VR sickness is based on subjective questionnaires. 
Various questionnaires have been previously developed to assess a sickness level. The 
most popular is probably the “Simulator Sickness Questionnaire” (SSQ) proposed by 
Kennedy in 1993 [14]. It is constituted of 16 questions to evaluate 3 categories of 
symptoms: nausea related symptoms, oculomotor symptoms and disorientation 
symptoms. 
While still widely used for the simplicity of its deployment and analysis, the SSQ has 
several limitations. Indeed, this measure is global, gathered a posteriori, intrusive and 
punctual. These limitations make the SSQ (and any other questionnaire) inadequate to be 
integrated in an automatic tool to evaluate VR sickness. Another method was proposed by 
Keshavarz and collaborators [15] which consists in requesting the participants to verbally 
give their evaluation of sickness level on a scale ranging from 0 to 20, with zero 
representing no discomfort and twenty representing barely supportable sickness. This 
approach seems to be a very good alternative to the SSQ since very strong correlation (r = 
.79) between verbal rating and SSQ scores were reported in this study. Nevertheless, this 
method is cognitively disruptive for the user experience in a context of VR-video games.   
To be effective and valuable for the VR industry, the assessment method must ideally be 
continuous, automatic and real time. Considering these constraints, physiological data 
related to the perceived VR sickness was used in this paper.  
        
The physiological measures of VR sickness 
The physiological response associated to VR sickness is due to the connections between 
the vestibular and the autonomic nervous system. The conflicting inputs from visual, 
vestibular and somatosensory afferents induce a vestibular autonomic response. This 
response involves both the sympathetic and the parasympathetic systems and affects for 
instance the heart rate variability and the skin conductance [16]. 
Various researches support the hypothesis of a measurable VR sickness by physiological 
response. For instance, Gavgani and collaborators [17] underline a correlation between 
phasic skin conductance activity and the reported nausea ratings. While Dennison [18] 
found relations between subscale scores of the SSQ and bradygastric power, breathing 
rate, pulse amplitude and blinking. Moreover, Ohyama and collaborators [19] investigated 
the cardiac responses associated to VR sickness. But, cardiac responses didn’t statically 
correlate with the user subjective evaluation. 
These findings suggest the existence of a relation between the physiological responses 
and VR sickness. Nevertheless, such relation seems too complex to be exploited using 
classical analyses. To handle such complex data, Machine Learning approach has spread 
in recent years to go beyond the limits of classical statistical approaches. Nam and 
collaborators [20] use such method to detect nausea in VR using various bio-signals (EEG, 
ECG, PPG, SCL, EOG, SKT). Results seem promising as they are able to partially detect 
nausea in real time [20].  
Automatic recognition of VR sickness: the Machine Learning approach 
To automatically detect VR sickness using physiological data, the use of Machine Learning 
algorithms seem relevant. In this approach, physiological and declared VR sickness are 
mapped using Machine Learning algorithms. In others words, the training of Machine 
Learning algorithms, using the supervised techniques [21], aims to infer the function 
between the input data (i.e., physiological data) and the output data (i.e., subjective 
labels). Indeed, Machine Learning algorithms have the ability to learn without being 
explicitly programmed [22]. After training, the models should be able to automatically 
recognize in real time, for any new user, the VR sickness related to the physiological data 
without requesting a subjective response. 
Physiological signals and subjective VR sickness level were collected to investigate the 
possibility of detecting VR sickness automatically. A large and relevant labeled dataset 
(i.e., physiological data labeled with subjective evaluation of VR sickness) to train models 
is fundamental to obtain an efficient system of VR sickness detection. So, Editorial user 
research lab, Ubisoft Paris and b<>com decided to cooperate with the intent to collect and 
analyze consistent amounts of physiological data of test users viewing VR content. 
Contrary to previous studies [19], [20] the aim of the current paper is to develop and 
evaluate a new solution more adapted to the industrial context than previous approaches 
based on invasive and/or expensive sensors (e.g., EEG or eye tracking). 
METHOD 
27 participants (22 men and 5 women - average age: 25.93 years; standard deviation: 
4.39) were recruited by Ubisoft. Participants were requested to test three VR game 
prototypes during 30 minutes. The prototypes were interactive games currently under 
        
development and they implied a relevant amount of camera’s movements. The first game 
was a space simulation using a third-person point of view. The second was an arcade car 
racing game (in first-person and third-person point of view) and the third was a space first-
person shooter. To increase the probability of VR sickness we didn’t implement in these 
prototypes any of the typical countermeasures (i.e. Reduction of the peripheral vision) 
applied in the gaming industry to prevent VR sickness. The participants were informed that 
they were free to stop the experiment at any time. 
In order to induce various levels of VR sickness, the game’s levels tested by the 
participants were designed to increase progressively the VR sickness induction. VR 
content was presented using the “Oculus Rift”1 ® or “HTC Vive” 2 ® devices. 
Measures 
Two types of measures were collected: the physiological data and subjective data of the 
users’ sickness.  
The physiological data was collected using the “Shimmer GSR+”®3. This sensor measures 
the electrodermal activity (EDA) and the Blood Pulse Volume (BVP) using 
PhotoPlethysmoGraphy (PPG) as the measure of cardiac activity. EDA sensors were 
placed on the middle phalanx of the non-dominant hand two first fingers. The data was 
collected in a continuous way during the experimental session and the sampling frequency 
was set at 128 Hz. 
The subjective data was collected following the method proposed by Keshavarz and 
collaborators [15] presented in the previous section. Participants were instructed to 
express their sickness level evaluation on a scale from 0 to 20 in response of auditory 
stimuli presented every 40 seconds. To grant the accuracy of the reply and the correct 
time alignment, the audio of the responses was recorded during each session and 
transcribed at the end of each experimental session. 
Features extraction 
The raw physiological signals appear very complex to interpret directly. So, it is generally 
necessary to extract specific features from raw signals. To extract these features, a 
toolbox was specially developed in Python. For this purpose, the raw signals were divided 
into subsamples of 30 seconds. For each of the 715 reported subjective responses, the 
last 30 seconds of physiological data (BVP and EDA) are used to extract the physiological 
features. 
Concerning the cardiac activity, two types of features are extracted [23]: time-domain 
features (HR, AVNN, SDNN, nn50, pNN50) and frequency-domain features (VLF, LF, 
LF/HF, Total Power). 
Concerning the EDA, the signal is composed of two components: a phasic and a tonic part 
[24]. The phasic part (also called Skin Conductance Level - SCL) corresponds to slow 
change in the EDA while the tonic part (also called Skin Conductance Responses - SCR) 
                                            
1
 https://www.oculus.com/rift/ 
2
 https://www.vive.com/eu/ 
3
 http://www.shimmersensing.com/products/shimmer3-wireless-gsr-sensor 
        
corresponds to the rapid physiological responses to a stimulus. The process of extracting 
those two components from the raw signal is constituted of different steps. A low-pass filter 
(cutoff frequency = 1Hz, order = 3) is firstly applied to reduce noise in the signal. Then, the 
tonic part of EDA is extracted from this filtered signal using a low-pass filter (cutoff 
frequency = 0.05Hz, order = 3) [25] and averaged over the whole filtered signal (mean 
EDA). The phasic part is obtained by subtracting the tonic signal to the filtered signal. On 
the phasic part, the SCR are manifested by peaks on signals. On these peaks4, the 
amplitude (mean, standard deviation, minimum and maximum) and half of recovery time 
(mean, standard deviation, minimum and maximum) are measured. Moreover, an 
Empirical Mode Decomposition [26] was applied to EDA signal to extract Intrinsic Mode 
Functions (IMF).  
Table 1.List of extracted physiological features 
BVP features EDA features 
HR (Heart Rate)  
AVNN (Average of all NN intervals) 
SDNN (Standard deviation of all NN 
intervals) 
rMMSD (Root-mean square differences of 
successive of all NN intervals) 
nn50 (The number of interval differences of 
successive NN intervals greater than 50 ms) 
pNN50 (Percentage of differences between 
adjacent NN intervals that are greater than 
50 ms) 
VLF (Total spectral power of all NN intervals 
between 0.003 and 0.04 Hz) 
LF (Total spectral power of all NN intervals 
between 0.04 and 0.15 Hz) 
HF (Total spectral power of all NN intervals 
between 0.15 and 0.4 Hz) 
LF/HF (Ratio of low to high frequency power) 
Total Power (Total spectral power) 
Mean EDA 
Amplitude: mean, standard deviation, 
minimum and maximum 
Half of recovery: mean, standard 
deviation, minimum and maximum 
IMF(1 to 3): mean, standard deviation, 
minimum and maximum 
RESULTS 
Analysis of correlation 
Based on the extracted features, Pearson correlations between the physiological features 
and the subjective data were computed. Only five correlations appear as significant. Of 
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 An EDA peak is especially characterized by the amplitude (the height of the peak) and the recovery time 
(time to return to the level EDA before the peak). 
        
these five correlations, three concern the EDA features: the Mean Amplitude of the EDA 
(r = .12), the Minimal Amplitude of the EDA (r = -.14) and the Maximal Amplitude of the 
EDA (r = -.07). The two remaining correlations concern cardiac features: the Heart Rate 
(r = .22) and the NN50 (r = .18). 
The majority of the 33 computed correlations appear as not significant. This can be the 
consequence of the multidimensional and nonlinear relationships between the 
physiological features and the subjective evaluation of VR. So, to handle such complex 
data and recognize VR sickness, Machine Learning techniques were used.  
Machine Learning 
In order to create an automatic tool to recognize VR sickness, Machine Learning models 
were trained. To test the performance of trained model, the dataset was randomly split in 
two independent parts: a training dataset and a testing dataset corresponding respectively 
to the 80% (572 samples) and the 20% (143 samples) of the original dataset. Then, three 
Machine Learning models were trained to select the most efficient model for our task. The 
three selected models were: 1) Random Forest, 2) Gradient Bosting and 3) Support Vector 
Machine.  
Regression models were chosen instead of classification models. Indeed, a continuous 
measure of VR sickness seems more adapted to represent the human perception 
compared to exclusive classes. Three metrics were computed for each method: RMSE 
(Root Mean Square Error), MAE (Mean Absolute Error) and R-Square (i.e., coefficient of 
determination)5.  
Table 2. Results for Random Forest, Gradient Boosting and Support Vector Machine 
Model RMSE MAE R-Squared 
Random Forest 1.52 1.15 .45 
Gradient Boosting 1.55 1.05 .48 
Support Vector Machine 1.57 1.31 .03 
 
According to these results, Gradient Boosting method seems to offer the best result with 
more variance explained and smaller error. 
CONCLUSION 
VR is potentially a major business opportunity with an exponential growth. But serious 
acceptability issues, in particular VR sickness, could interfere with the uptake of this 
technological breakthrough by the mass market. In this paper, a solution to detect the 
development of VR sickness based on physiological signals was tested. Models were 
trained to recognize VR sickness using Machine Learning methods and showed promising 
results (the best model explained 48% of the VR sickness variance). Indeed, the ability to 
evaluate in a continuous and automatic way the appearance of the users’ sickness seems 
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 RMSE and MAE evaluate the distance between the predicted data and the ground truth (0 corresponds to a 
perfect prediction). R-Square corresponds to the explained variance (it ranges from 0 to 1, with 1 indicates 
that the model explains all the variability of the output variable). 
        
a necessary stage to prevent VR sickness. Further research work will be conducted to 
confirm the results and evaluate the performance of the tool in real time.  
Lastly, this type of automatic system able to assess the level of VR sickness of the end 
user seems extremely valuable to all the stakeholders in the VR ecosystem. As a 
standalone application, this tool can in fact be used to assess the acceptability of the 
content (both videogames and 360° videos) in the early stages of the production chain or 
can be used to validate the efficiency of sickness reduction strategies (e.g., reduction of 
the FOV). 
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